Zinc Ions Prevent Processing of Caspase-3 During Apoptosis Induced by Geranylgeraniol in HL-60 Cells
Overview
Affiliations
Geranylgeraniol (GGO) at 50 microM induces apoptosis in HL-60 cells. We examined the effects of Zn2+ ions on this process. Treatment of HL-60 cells with Zn2+ ions inhibited subsequent GGO-induced fragmentation of DNA. In a cell-free system that consisted of a specific substrate for caspase-3 and a lysate of HL-60 cells that had been treated with 50 microM GGO, Zn2+ ions at concentrations above 0.1 mM inhibited the activity of caspase-3. The effect of Zn2+ ions on the processing of caspase-3 during GGO-induced apoptosis was investigated by Western blotting, which revealed that an inactive 32-kDa precursor of caspase-3 was cleaved, in response to GGO, to yield an activated 17-kDa enzyme. Treatment of HL-60 cells with Zn2+ ions inhibited the cleavage of the precursor by a protease that was induced by treatment with GGO, and inhibition of this processing was well correlated with the inhibition by Zn2+ ions of caspase-3 activity in the cell-free system. In cell-extracted cytosols, Zn2+ ions inhibited the cleavage of the 32-kDa precursor by caspase-9 (Aapf-3) that was activated by addition of cytochrome c and dATP. These results indicate that inhibition of GGO-induced apoptosis in HL-60 cells by Zn2+ ions might be due to inhibition by Zn2+ ions of the processing of a precursor to caspase-3.
Liu Y, Zhu H, Hong H, Wang W, Liu F Bone Joint Res. 2017; 6(12):649-655.
PMID: 29203637 PMC: 5935811. DOI: 10.1302/2046-3758.612.BJR-2016-0137.R2.
Dietary zinc modifies diabetic-induced renal pathology in rats.
Elsaed W, Mohamed H Ren Fail. 2016; 39(1):246-257.
PMID: 27882813 PMC: 6014501. DOI: 10.1080/0886022X.2016.1256321.
Ikeda K, Inoue K, Kida C, Uwamori T, Sasaki A, Kanematsu S Appl Environ Microbiol. 2013; 79(12):3684-91.
PMID: 23563943 PMC: 3675941. DOI: 10.1128/AEM.00426-13.
Filipiak M, Tylko G, Pyza E Biometals. 2012; 25(3):507-16.
PMID: 22367497 PMC: 3349848. DOI: 10.1007/s10534-012-9530-1.
Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound.
Peterson Q, Hsu D, Novotny C, West D, Kim D, Schmit J Cancer Res. 2010; 70(18):7232-41.
PMID: 20823163 PMC: 3113694. DOI: 10.1158/0008-5472.CAN-10-0766.